These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 825358)

  • 21. Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited.
    Legnani C; Preda L; Palareti G; Lunghi B; Rossi E; Coccheri S
    Haematologica; 2002 Feb; 87(2):182-8. PubMed ID: 11836169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of exogenous heparin on heparinemia and coagulation in coronary arteriosclerosis].
    Szigeti I; Kótay-Lákatos E; Vertán MZ; Kiss R
    Med Interna (Bucur); 1967 May; 19(5):549-52. PubMed ID: 6077944
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of the changes in the blood coagulation system in the dynamics of treating ischemic insult with anticoagulants].
    Lobkova TN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):645-51. PubMed ID: 4268851
    [No Abstract]   [Full Text] [Related]  

  • 24. The effects of caffeine on free fatty acids and blood coagulation parameters of dogs.
    Bellet S; Feinberg LJ; Sandberg H; Hirabayashi M
    J Pharmacol Exp Ther; 1968 Feb; 159(2):250-4. PubMed ID: 5638645
    [No Abstract]   [Full Text] [Related]  

  • 25. A comprehensive model for the humoral coagulation network in humans.
    Wajima T; Isbister GK; Duffull SB
    Clin Pharmacol Ther; 2009 Sep; 86(3):290-8. PubMed ID: 19516255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. I. Effects of heparin fractions.
    Schmitz-Huebner U; Balleisen L; Asbeck F; van de Loo J
    Thromb Haemost; 1981 Oct; 46(3):612-6. PubMed ID: 7031982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-frozen transports of whole blood samples do not cause relevant bias for global coagulation tests in clinical trials evaluating the drug safety.
    Totzke U; Kuyas C
    Contemp Clin Trials; 2005 Aug; 26(4):488-502. PubMed ID: 16054581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Activated coagulation time and the concentration of heparin in assessing the level of blood heparinization during operations using artificial blood circulation].
    Khodas MIa; Piatnitskaia GKh; Savina ME; Smirnova LA
    Anesteziol Reanimatol; 1989; (2):11-5. PubMed ID: 2742179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Present state of heparin therapy].
    Blatrix C; Soulier JP; Vacheron A; Cornu P
    Presse Med (1893); 1969 Mar; 77(15):553-6. PubMed ID: 5796027
    [No Abstract]   [Full Text] [Related]  

  • 30. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Theory and experience behind the use of coagulation tests in diagnosis and prognosis of liver disease.
    Koller F
    Scand J Gastroenterol Suppl; 1973; 19():51-61. PubMed ID: 4515641
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blood coagulation and excretion of coagulation and fibrinolysis factors with urine of patients with diffuse glomerulonephritis].
    Zorina SS; Krasik IaD
    Ter Arkh; 1974; 46(7):54-62. PubMed ID: 4408677
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of heparin on the prothrombin time.
    Schultz NJ; Slaker RA; Rosborough TK
    Pharmacotherapy; 1991; 11(4):312-6. PubMed ID: 1923913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of heparinase to eliminate heparin inhibition in routine coagulation assays.
    Hutt ED; Kingdon HS
    J Lab Clin Med; 1972 Jun; 79(6):1027-34. PubMed ID: 5025456
    [No Abstract]   [Full Text] [Related]  

  • 35. Circulating heparin during liver transplantation.
    Chapin JW; Peters KR; Winslow J; Becker GL; Skinner H
    Transplant Proc; 1993 Apr; 25(2):1803. PubMed ID: 8470172
    [No Abstract]   [Full Text] [Related]  

  • 36. [Blood coagulation and fibrinolysis in dogs during stimulation of the vagus nerve].
    Mishchenko VP; Kuznik BI
    Fiziol Zh SSSR Im I M Sechenova; 1975 Jan; 61(1):101-7. PubMed ID: 1109963
    [No Abstract]   [Full Text] [Related]  

  • 37. Modification of the heparin clotting time (heparin prothrombin time).
    LOSNER S; VOLK BW
    Tech Bull Regist Med Technol; 1957 Feb; 27(2):35-41. PubMed ID: 13422312
    [No Abstract]   [Full Text] [Related]  

  • 38. Modification of the heparin clotting time (heparin prothrombin time).
    LOSNER S; VOLK BW
    Am J Clin Pathol; 1957 Mar; 27(3):353-9. PubMed ID: 13410867
    [No Abstract]   [Full Text] [Related]  

  • 39. "Per cent prothrombin activity" unacceptable.
    Soloway HB
    N Engl J Med; 1973 Mar; 288(13):688. PubMed ID: 4687263
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of heparin on the prothrombin time.
    LONG M; HURN M; BARKER NW
    Proc Staff Meet Mayo Clin; 1946 Jun; 21():225-9. PubMed ID: 20987542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.